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Febrile neutropenia is a common consequence of anticancer chemotherapy, fever being defined as a single oral temperature of more than or equal to 38.3°C with a neutrophil count of less than 500 cells/mm 3 Since febrile neutropenic patients fail to mount a full inflammatory response, and the current diagnostic tests are not sufficiently rapid, sensitive or specific for identifying or excluding the microbial cause of a febrile episode, these patients may have to be treated empirically. The risk of infection increases ten-fold with declining neutrophil counts. It has been shown that with absolute neutrophil counts between 100 and 500/mm 3 , infection rates rise from 0.5 to 5 infections per 100 days, while 16 -20% of patients with neutrophil counts less than 100/mm 3 have bacteremia (Hughes et al, 1997, level 1). The prompt institution of empiric antibiotic therapy for febrile neutropenic patients, without waiting 24 to 48 hours for the results of blood cultures, has been shown to dramatically reduce infection-related morbidity and mortality in the cancer population undergoing chemotherapy (Freifeld & Pizzo, 1997, level 9) . Empiric antibiotic therapy has become a standard of care for the febrile neutropenic patient. Numerous clinical trials have demonstrated that any one of a number of empiric antibiotic regimens may preserve the patient through the critical time of fever and neutropenia, including a variety of antibiotic combinations and more recently potent antibiotic monotherapies (Freifeld & Pizzo, 1997, level 9) . Consequently, there is universal agreement in the literature that broad spectrum antibiotics should be instituted for all cases of febrile neutropenia because of the significant morbidity and mortality associated with bacterial sepsis in patients with fever and cancer (Freifeld & Pizzo, 1997, level 9 ). 
RECOMMENDATIONS

Bacterial Aetiological Agents
Viral Aetiological Agents
CLINICAL ASSESSMENT AND INVESTIGATION
3.1
Clinical Diagnosis Viral and bacterial pneumonia cannot be distinguished on clinical features alone. However, clinical signs such as tachypnoea (defined by WHO's ARI case management guideline as respiratory rate > 60/min.in infants under 2 months, > 50/min in infants 2 -12 months and > 40/min for children more than 12 months) is a useful sign, where the severity of the tachypnoea relates to the severity of the illness. In children older than 3 years, pneumonia can occur even in the absence of tachypnoea.
Fever is an important clinical sign. A young child with mild symptoms and low grade temperature is most likely to have a viral infection, whereas, high fever of more than 39°C with a history of rapid onset, with signs and symptoms of respiratory distress is suggestive of pneumonia of bacterial origin.
Wheezing is likely to be associated with viral lower respiratory infection in younger children. However, when wheezing is present in older school-going children associated with fever, headache, arthralgia and cough, mycoplasma infection has to be considered. While auscultatory findings are not useful in differentiating viral from bacterial causes, the presence of staphylococcal skin infections or history of contact may point to the probable cause causative agent.
3.2
Laboratory Diagnosis Laboratory investigations to establish the aetiological agent are not indicated in children with community acquired pneumonias well enough to receive ambulatory treatment. However, in children with pneumonias requiring inpatient treatment, investigations to identify the probable aetiological agents should be carried out:
i. Culture of lung aspirate/pleural fluids, nasopharyngeal secretions and blood sample. Invasive procedures like biopsy or needle aspirate of lung tissues are rarely carried out in children with acute pneumonias. Where significant pleural effusion is present, the pleural fluid is aspirated for culture, direct microscopic examination and antigen detection. Nasopharyngeal bacterial secretions correlate poorly while viral culture is time consuming. Blood culture should be done for any ill child with pneumonia, for which most studies report not more than 10% positive results.
ii. Rapid antigen identification for viral pathogens especially RSV should be carried out for young infants with lower respiratory tract infections.
iii. Serological testing for Mycoplasma pneumonie, if available, may be considered to assist in the management of suspected cases.
MANAGEMENT
Pneumonia in young children with mild symptoms of lower respiratory infections are likely to be viral in aetiology and hence antibiotics need not be used 
INTRODUCTION
Bacterial meningitis is defined as an inflammation of the pia -arachnoid meninges and the fluid residing in the space that it encloses. The infective agent upon entry will extend to all the sub-arachnoid space, which is continuous around the brain, spinal cord and optic nerves. The ventricular fluid becomes infected as well.
Aseptic meningitis refers to meningitis with CSF pleocytosis but an aetiological agent is not apparent on CSF gram stain and bacterial culture. Clinicians who assess children with aseptic meningitis recognize that the majority of cases are caused by viruses but are often faced with having to exclude partially treated bacterial meningitis in children who had been on oral antibiotics. 
Bacterial meningitis
Neisseria Meningitides Meningitis
ADJUVANT DEXAMETHASONE ADMINISTRATION IN BACTERIAL MENINGITIS.
Dexamethasone reduces the inflammatory response in CSF in bacterial meningitis, but also reduces the penetration of antibiotics, especially Vancomycin The outcome is affected by the causative agents, with infections due to gram negative rods having a significantly higher mortality (25%) than gram-positive bacteria (10%) (Oda & Matsuo, 2000, level 7) . In Kuwait it was found that 52% of the 70 deaths in patients were due to nosocomial bacteremia (Jamal & El-Din, 1999 , level 7). 
INVESTIGATIONS
MANAGEMENT
With respect to management, apart from antibiotic administration, supportive strategies are essential to optimize outcome.
Community Acquired Bacterial Sepsis in Previously Healthy Children (i)
Sepsis with no obvious source or with respiratory or urinary tract infection, or central nervous system involvement Though the commonly used antibiotics are cloxacillin/penicillin and a third generation cephalosporin/gentamycin, no evidence could be obtained related to their use (Grade C).
(ii) Sepsis with genito-urinary or gastrointestinal tract involvement The commonly used antibiotics are a third generation cephalosporin or gentamycin with metronidazole for intra-abdominal infections, but again no evidence could be obtained related to their use (Grade C).
3.2
Nosocomial Sepsis There are multiple causative agents that cause nosocomial sepsis in children. It is therefore recommended that the use of antibiotics be dependent on the causative agents.
3.3
Adjuvant therapy It has been found that Polyclonal Intravenous Immunoglobulin significantly reduces mortality and can be used as adjuvant treatment for sepsis and septic shock, but the number of patients involved in this study was small ( 
INTRODUCTION
Neonates, especially premature babies, are predisposed to infection as they are deficient in host defences and are at risk of acquiring infections from mothers during the perinatal period (Anwer et al, 2000, level 8) . In order to rationalise the use of antibiotics, continuous surveillance is recommended with emphasis on primary prevention and prevention of cross infection (Musoke, 1997, level 9).
CLINICAL PRESENTATION
Early clinical presentation of sepsis in newborn includes hypothermia, hyperthermia, poor feeding, poor weight gain, lethargy, hypotonia, pallor, mottled skin, irritability, jaundice, vomiting, ileus, pseudoparalysis, apnea, tachypnoea, cardiovascular signs, hemorrhagic diasthesis and sclerema. Late signs are usually specific to a single organ system. Septicemic shock and death often occur within 12 hours of the first sign of illness , level 8).
DIAGNOSIS AND INVESTIGATIONS
Early diagnosis and therapy initiated on the basis of clinical suspicion is important. Criteria for treatment could be defined by limited predictors or parameters as follows: In a local study, the incidence of nososcomial sepsis was 32.6% of whom 43.3% died, and 80% of the babies had gram negative organisms (Halder et al, 1999, level 9) Fungal: For treatment of Candida species (Ronnestad et al, 1998, level 9) , amphotericin has been found to be effective in babies at risk for fungal infections and blood culture confirmed 
